Site Upgraded to latest version. If any issues please contact us

U.S. Policy on Cuba Obstructs Crucial Breakthroughs in Alzheimer's, Cancer

alt

U.S. Policy on Cuba Obstructs Crucial Breakthroughs in Alzheimer's, Cancer

In July 2017, before the new policy was imposed, Cuban neuroscientist Marquiza Sablón traveled to Washington University in St. Louis (WUSTL) as a participant in the AAAS Cuban Biomedical Fellows program. At her home institution, the Cuban Neurosciences Center, Sablón had developed compounds with the potential to detect Alzheimer’s disease when tagged with radioactive isotopes, a promising new technology that could potentially be used for diagnosis and early detection based on nuclear imaging techniques. By the time
of her departure at the end of December, Sablón said her “research goal was reached with the use of a radionuclide produced at WUSTL,” and she and her U.S. colleagues hoped to publish an article on the research to share their findings with other pioneers in the field."


By AAAS, USA.


Technology Policy Resource.